Elevated serum HGF levels have been associated with resistance to EGFR inhibitors in KRAS wild-type colorectal cancer [97] and lung cancer [97,98,99], but no evidence exists for this relationship in HNSCC. Here, HGF is linked to head and neck squamous cell carcinoma.